<DOC>
	<DOCNO>NCT01870466</DOCNO>
	<brief_summary>The purpose study evaluate pharmacodynamic drug interaction cilostazol statin ( simvastatin CYP3A substrate rosuvastatin non-CYP3A substrate ) healthy male subject .</brief_summary>
	<brief_title>Pharmacodynamic Drug Interaction Between Cilostazol Statins</brief_title>
	<detailed_description>Subjects suitable study visit Clinical Trial Center , Samsung Medical Center 7 day pharmacodynamic sampling perform follow administration study drug .</detailed_description>
	<mesh_term>Cilostazol</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Healthy male subject age 20 55 year A body mass index range 18.5 27 kg/m2 Willingness participate entire study period Written inform consent fully inform study procedures Any past medical history hepatic , renal , neurologic , cardiovascular , respiratory , endocrine , hematooncologic psychiatric disease Active bleeding bleeding tendency History gastrointestinal disease surgery possibly affect drug absorption History clinically significant drug hypersensitivity Use medication within 7 day first dose Heavy drinker ( &gt; 140 g/week ) Whole blood donation 60 day study Judged eligible study participation investigator</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>